Oragenics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2002
Net Income	-20.26	-20.66	-14.29	-15.71	-26.43	-15.57	Upgrade
Depreciation & Amortization	0.02	0.03	0.04	0.04	0.05	0.06	Upgrade
Share-Based Compensation	1.01	1.02	0.74	1.69	1.49	0.55	Upgrade
Other Operating Activities	10.99	12.32	-1.73	0.51	7.93	1.94	Upgrade
Operating Cash Flow	-8.25	-7.29	-15.23	-13.47	-16.95	-13.01	Upgrade
Capital Expenditures	0.06	0.06	-0.12	-0.04	0	-0.03	Upgrade
Acquisitions	-1	-1	0	0	0	0	Upgrade
Investing Cash Flow	-0.94	-0.94	-0.12	-0.04	0	-0.03	Upgrade
Share Issuance / Repurchase	2.69	0.85	0.07	29.3	16.52	11.35	Upgrade
Debt Issued / Paid	-0.59	-0.57	-0.56	-0.52	-0.2	-0.25	Upgrade
Other Financing Activities	-	-	-	-5.64	-	-	Upgrade
Financing Cash Flow	2.1	0.28	-0.49	23.14	16.32	11.1	Upgrade
Net Cash Flow	-7.09	-7.94	-15.84	9.63	-0.63	-1.94	Upgrade
Free Cash Flow	-8.18	-7.23	-15.34	-13.51	-16.95	-13.04	Upgrade
Free Cash Flow Margin	-39666.09%	-19194.13%	-11666.58%	-15535.76%	-	-	Upgrade
Free Cash Flow Per Share	-2.34	-3.21	-7.64	-6.96	-17.99	-18.50	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).